Huiyu Pharmaceutical Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
1,366
- Stock Symbol
-
688553
- Investments
-
2
- Share Price
-
$1.33
- (As of Friday Closing)
Huiyu Pharmaceutical General Information
Description
Sichuan Huiyu Pharmaceutical Co Ltd is engaged in the research and development, production and sales of anti-tumor and injection drugs.
Contact Information
Website
www.huiyupharma.comCorporate Office
- No. 5 Road, Chengxi Industrial Park
- Neijiang, Sichuan 641000
- China
Corporate Office
- No. 5 Road, Chengxi Industrial Park
- Neijiang, Sichuan 641000
- China
Huiyu Pharmaceutical Stock Performance
As of 20-Nov-2026, Huiyu Pharmaceutical’s stock price is $1.33. Its current market cap is $831M with 626M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.33 | $1.41 | $1.32 - $2.54 | $831M | 626M | 11.2M | $0.04 |
Huiyu Pharmaceutical Financials Summary
As of 30-Sep-2026, Huiyu Pharmaceutical has a trailing 12-month revenue of $163M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 888,915 | 774,324 | 602,100 | 563,581 |
| Revenue | 162,797 | 138,799 | 152,517 | 131,038 |
| EBITDA | 1,172 | (2,249) | 56,515 | 22,218 |
| Net Income | 18,739 | (3,471) | 45,348 | 19,758 |
| Total Assets | 777,270 | 717,410 | 707,610 | 661,011 |
| Total Debt | 104,907 | 86,217 | 79,714 | 60,891 |
Huiyu Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Huiyu Pharmaceutical Patents
Huiyu Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026108837-A1 | Salt form of pyridazine derivative, crystal form, method for preparing same, and use thereof | Pending | 21-Nov-2024 | ||
| AU-2025214341-A1 | Bispecific antibody-cytokine fusion protein and use thereof | Pending | 31-Jan-2024 | ||
| EP-4825879-A1 | Bispecific antibody-cytokine fusion protein and use thereof | Pending | 31-Jan-2024 | ||
| WO-2025162198-A1 | Bispecific antibody-cytokine fusion protein and use thereof | Pending | 31-Jan-2024 | ||
| AU-2024351848-A1 | Liposome drug delivery system and preparation method therefor, liposome formulation, use, and fat reduction drug or medical aesthetic product comprising liposome formulation | Pending | 27-Sep-2023 | A61K31/575 |
Huiyu Pharmaceutical Signals
Huiyu Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Huiyu Pharmaceutical Investments (2)
Huiyu Pharmaceutical’s most recent deal was a Later Stage VC with TYK Medicines for . The deal was made on 15-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TYK Medicines | 15-Jan-2024 | Later Stage VC | Drug Discovery | ||
| South Pharmaceutical | 25-Jan-2021 | Later Stage VC | Drug Discovery |
Huiyu Pharmaceutical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Huiyu Pharmaceutical Exits (1)
Huiyu Pharmaceutical’s most recent exit was on 15-Jan-2024 from TYK Medicines. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| TYK Medicines | 15-Jan-2024 | Completed |
|
Huiyu Pharmaceutical FAQs
-
When was Huiyu Pharmaceutical founded?
Huiyu Pharmaceutical was founded in 2010.
-
Where is Huiyu Pharmaceutical headquartered?
Huiyu Pharmaceutical is headquartered in Neijiang, China.
-
What is the size of Huiyu Pharmaceutical?
Huiyu Pharmaceutical has 1,366 total employees.
-
What industry is Huiyu Pharmaceutical in?
Huiyu Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Huiyu Pharmaceutical a private or public company?
Huiyu Pharmaceutical is a Public company.
-
What is Huiyu Pharmaceutical’s stock symbol?
The ticker symbol for Huiyu Pharmaceutical is 688553.
-
What is the current stock price of Huiyu Pharmaceutical?
As of 20-Nov-2026 the stock price of Huiyu Pharmaceutical is $1.33.
-
What is the current market cap of Huiyu Pharmaceutical?
The current market capitalization of Huiyu Pharmaceutical is $831M.
-
What is Huiyu Pharmaceutical’s current revenue?
The trailing twelve month revenue for Huiyu Pharmaceutical is $163M.
-
What is Huiyu Pharmaceutical’s annual earnings per share (EPS)?
Huiyu Pharmaceutical’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process